Free Cash Flow Chart

View Free Cash Flow for BDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 -8.310M
June 30, 2025 -14.30M
December 31, 2024 -16.60M
June 30, 2024 -11.07M
December 31, 2023 -8.807M
June 30, 2023 -8.479M
December 31, 2022 -8.336M
June 30, 2022 -8.677M
December 31, 2021 -8.643M
June 30, 2021 -7.990M
December 31, 2020 -12.46M
Date Value
June 30, 2020 -11.72M
December 31, 2019 -8.598M
June 30, 2019 -12.99M
December 31, 2018 -18.49M
June 30, 2018 -16.33M
December 31, 2017 -19.14M
June 30, 2017 -20.30M
December 31, 2016 -18.29M
June 30, 2016 -23.27M
December 31, 2015 -20.25M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
NuCana Plc -6.612M
Mereo BioPharma Group Plc -25.58M
BioNTech SE 424.34M
Silence Therapeutics Plc -41.79M
Autolus Therapeutics Plc -240.12M

Free Cash Flow Related Metrics